These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 9526201)

  • 21. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
    Su WJ; Perng RP
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1029-32. PubMed ID: 12475151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical outcome of mycobacterium other than mycobacterium tuberculosis pulmonary disease.
    Tsunezuka Y; Sato H; Hiranuma C
    Thorac Cardiovasc Surg; 2000 Oct; 48(5):290-3. PubMed ID: 11100762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
    Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The combination of amoxicillin-clavulanic acid and ofloxacin in the treatment of multidrug-resistant Mycobacterium tuberculosis].
    Iwanaga T; Yokota K; Kishikawa R; Ikeda T; Tsurutani H; Hirose T; Nishima S
    Kekkaku; 1997 Jan; 72(1):9-13. PubMed ID: 9038010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimycobacterial drugs.
    Heifets LB
    Semin Respir Infect; 1994 Jun; 9(2):84-103. PubMed ID: 7973175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Advances and principles in tuberculostatic therapy].
    Bethge H
    Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130
    [No Abstract]   [Full Text] [Related]  

  • 27. Isoniazid induced gynaecomastia: a case report.
    Garg R; Vaibhav ; Mehra S; Prasad R
    Indian J Tuberc; 2009 Jan; 56(1):51-4. PubMed ID: 19402273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M; Nakajima Y
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effectiveness of intermittent chemotherapy in the combined treatment of patients with recently diagnosed destructive tuberculosis of the lungs].
    Osiĭnskiĭ IIu; Berezovskiĭ BA
    Probl Tuberk; 1989; (5):56-9. PubMed ID: 2748559
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
    Grumbach F
    Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
    [No Abstract]   [Full Text] [Related]  

  • 32. [Case of pulmonary infection with Mycobacterium chelonae in healthy breast-feeding woman].
    Suzuki K; Matsuki A; Saito K; Tanaka Y
    Kekkaku; 2007 Oct; 82(10):759-63. PubMed ID: 18018600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pulmonary infection caused by Mycobacterium gordonae in immunocompetent patient].
    Fujita Y; Matsumoto H; Fujikane T; Nakao S; Sasaki N; Takahashi M; Sato K; Takeda A; Yamazaki Y; Tobise K
    Kekkaku; 2000 Apr; 75(4):369-74. PubMed ID: 10808280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycobacterium szulgai in a patient with advanced acquired immunodeficiency syndrome: an unusual pathogen with unusual multidrug resistance.
    Kang-Birken SL; Prichard JG
    Pharmacotherapy; 2006 Nov; 26(11):1646-9. PubMed ID: 17064210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pulmonary infection due to Mycobacterium szulgai associated with multiple bullous disease of the lung].
    Mori K; Yoshikawa M; Nakamura T; Tomoda K; Nakaya M; Fu A; Tokuyama T; Fukuoka K; Yamamoto C; Tsukaguchi K
    Kekkaku; 1995 Sep; 70(9):511-6. PubMed ID: 8523857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A study on experimental mycobacterioses provoked by atypical mycobacteria. 2. Combined antituberculous chemotherapy against conventional mice infected intravenously with Mycobacterium intracellulare (author's transl)].
    Kuze F; Lee Y; Maekawa N; Suzuki Y
    Kekkaku; 1979 Sep; 54(9):453-60. PubMed ID: 502152
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial].
    Tanaka E
    Kekkaku; 1996 Sep; 71(9):547-9. PubMed ID: 8999140
    [No Abstract]   [Full Text] [Related]  

  • 39. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
    Kobashi Y; Oka M
    Kekkaku; 2008 Dec; 83(12):779-84. PubMed ID: 19172823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemotherapeutic regimens that were considered effective to cure pulmonary infection caused by Mycobacterium avium-Mycobacterium intracellulare complex].
    Tsukamura M
    Kekkaku; 1991 May; 66(5):375-80. PubMed ID: 1875580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.